Skip to main content
. 2022 Aug 22;13:969912. doi: 10.3389/fimmu.2022.969912

Figure 2.

Figure 2

(A, B) Rash that developed 18 days after the first administration of SMZ-TMP. SMZ-TMP, sulfamethoxazole-trimethoprim.